Healthcare >> CEO Interviews >> June 8, 1998
ROBERT S. WHITEHEAD has served as President & CEO of the Trega
Biosciences, Inc. and as a Director since August 1993. Mr. Whitehead was
also appointed the Company's Chairman of the Board of Directors in
February 1998. Prior to joining Trega, he was senior vice president,
Commercial Operations, Solvay Pharmaceuticals ('Solvay') from February
1992 to April 1993. Before Solvay, Mr. Whitehead worked at Searle
Pharmaceuticals where, for 13 years, he held such positions as president
and general manager, Searle Canada, from March 1989 to February 1992;
vice president, International Marketing Operations, director of
Marketing, Europe; and vice president, Sales and Marketing, Searle de
Mexico. Mr. Whitehead is on the Board of Directors of Spiros Development
Corporation II, Inc. He graduated from Temple University with a degree
in Pre-Medicine. Profile
then bring us up-to-date. Over the next two to three years, what do you
see as the key challenges and opportunities for the
